Category Cartee11749

Cartee11749

Stock atra

by Publisher
ATRA: Get the latest Atara Biotherapeutics stock price and detailed information including ATRA news, historical charts and realtime prices.

Researching Atara Biotherapeutics (NASDAQ:ATRA) stock? View ATRA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC  Based on 4 Wall Street analysts offering stock ratings for Atara Biotherapeutics in the last 3 months (by analysts ranked 0 to 5 stars). All Analysts. Top Analysts  Atara Biotherap stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Portfolio) disclosed on Monday that he increased his stake in Atara Biotherapeutics Inc. (ATRA). Trade details Klarman invested in 895,000 shares of Atara for  View today's stock price, news and analysis for Atara Biotherapeutics Inc. (ATRA) . Barron's also provides information on historical stock ratings, target prices,  The average Atara Biotherapeutics stock price for the last 52 weeks is 18.61. Compare ATRA With Other Stocks 

March 7, 2020 - The year-to-date (YTD) return or performance of Atara Bio (ATRA) is down -24.41% and is underperforming the overall stock market by -16.45%. Recently, the weekly return of Atara Bio (ATRA) is up 2.47% and is outperforming the overall market by 2.37%.

ATRA: Get the latest Atara Biotherapeutics stock price and detailed information including ATRA news, historical charts and realtime prices. View live ATARA BIOTHERAPEUTICS INC chart to track its stock's price action. Find market predictions, ATRA financials and market news. Researching Atara Biotherapeutics (NASDAQ:ATRA) stock? View ATRA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC  Based on 4 Wall Street analysts offering stock ratings for Atara Biotherapeutics in the last 3 months (by analysts ranked 0 to 5 stars). All Analysts. Top Analysts  Atara Biotherap stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Portfolio) disclosed on Monday that he increased his stake in Atara Biotherapeutics Inc. (ATRA). Trade details Klarman invested in 895,000 shares of Atara for 

Get breaking news and analysis on Atara Biotherapeutics, Inc. (ATRA) stock, price quote and chart, trading and investing tools.

Current and historical daily P/E ratio for ATRA (Atara Biotherapeutics) from 2014 to Dec 15 2019.The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number.

3 Mar 2020 Today's big question for investors is, “what's going on with Atara Biotherapeutics, Inc. (NASDAQ:ATRA) stock?…

Atara Biotherapeutics (ATRA) Mizuho Securities also maintained a Buy rating on the stock with a $43.00 price target. Globus Medical (GMED) In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on Globus Medical, with a price target of $65.00. The company's shares closed last Monday at $56.45. ATRA has traded in a range of $10.38 to $41.97 in the last 1 year. The stock closed yesterday's (Feb.10) trading at $14.37, up 9.03%. For comments and feedback contact: editorial@rttnews.com. Business News

Find the latest Atara Biotherapeutics, Inc. (ATRA) stock quote, history, news and other vital information to help you with your stock trading and investing.

ATRA stock quote, chart and news. Get Atara Biotherapeutics, Inc.'s stock price today. Atara Biotherapeutics, Inc. (ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today reported financial results for the fourth quarter and full year ended December 31, 2019 and recent business highlights. A completed technical price pattern on the stock chart is currently suggesting that much higher Atara Biotherapeutics (NASDAQ: ATRA) stock prices are on the horizon. View live ATARA BIOTHERAPEUTICS INC chart to track its stock's price action. Find market predictions, ATRA financials and market news.

Get Atara Biotherapeutics Inc (ATRA:NASDAQ) real-time stock quotes, news and financial information from CNBC. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Learn about ATRA with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on ATRA. Why Atara Biotherapeutics Stock Is Imploding Today ATRA), a leader in the off-the-shelf adoptive cell therapy space, lost as much as 22% of their value in early morning trading today. What ATRA: Get the latest Atara Biotherapeutics stock price and detailed information including ATRA news, historical charts and realtime prices. This website uses cookies and similar technologies to optimise and improve the experience on our site. By continuing to use this website, you agree to the use of View today's stock price, news and analysis for Atara Biotherapeutics Inc. (ATRA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation